Abnormalities of endothelial function in patients with predialysis renal failure

Heart

Volumn 83, Issue 2, 2000, Pages 205-209

  Thambyrajah, J ^a   Landray, M J ^a   McGlynn, F J ^b   Jones, H J ^a   Wheeler, D C ^b   Townend, J N ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Atherosclerosis; Endothelial function; Flow mediated dilatation; Renal failure

Indexed keywords

GLYCERYL TRINITRATE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPEREMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREMIA;

EID: 0034111466     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.2.205     Document Type: Article

References (30)

1. 1 Jungers P, Massy ZA, Khoa TN, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997;12:2597-602.
2. 2 Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7:158-65.
3. 3 Raine AE, Margreiter R, Brunner FP, et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992;2:7-35.
4. 4 Excerpts from the USRDS 1996 annual data report. Am J Kidney Dis 1996;28:S79-102.
5. 5 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
6. 6 Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-15.
7. 7 Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
8. 8 Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41.
9. 9 Sadler JE. von Willebrand factor. J Biol Chem 1991;266: 22777-80.
10. 10 Meade TW, Cooper JA, Stirling Y, et al. Factor VIII, ABO blood group and the incidence of ishaemic heart disease. Br J Haematol 1994;88:601-7.
11. 11 Boneu B, Abbal M, Plante J, et al. Factor-VIII complex and endothelial damage [letter]. Lancet 1975;i:1430.
12. 12 Takagi M, Wada H, Mukai K, et al. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis. Blood Coagul Fibrinolysis 1994;5:713-17.
13. 13 van Guldener C, Lambert J, Janssen MJ, et al. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 1997,2:14-18.
14. 14 van Guldener C, Janssen MJ, Lambert J, et al. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. Nephrol Dial Transplant 1998;13:106-12.
15. 15 Joki N, Hase H, Nakamura R, et al. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997;12: 718-23.
16. 16 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
17. 17 Meredith IT, Currie KE, Anderson TJ, et al. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996;270: H1435-40.
18. 18 Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-19.
19. 19 McLenachan JM, Vita J, Fish DR, et al. Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation 1990;82:1169-73.
20. 20 Harrison DG, Armstrong ML, Freiman PC, et al. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987;80:1808-11.
21. 21 Kari JA, Donald AE, Vallance DT, et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997;52:468-72.
22. 22 Kuriyama S, Tomonari H, Yoshida H, et al. Endothelial cell dysfunction in patients with impaired renal function [In Japanese]. Jpn J Nephrol 1996;38:372-8.
23. 23 Haaber AB, Eidemak I, Jensen T, et al. Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure. J Am Soc Nephrol 1995;5:1581-4.
24. 24 Upchurch GR, Welch GN, Loscalzo J. Homocysteine, EDRF, and endothelial function. J Nutr 1996;126(suppl 4):1290-4S.
25. 25 Murad F, Arnold WP, Mittal CK, et al. Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP. Adv Cyclic Nucleotide Res 1979;11:175-204.
26. 26 Luscher TF, Tanner FC, Noll G. Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions. Curr Opin Lipidol 1996;7:234-40.
27. 27 Vallance P, Leone A, Calver A, et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancer 1992;339:572-5.
28. 28 Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-18.
29. 29 Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992;89:10-18.
30. 30 Culleton BF, Larson MG, Wilson PWF, et al. Prevalence and outcomes of mild renal insufficiency in the community [abstract]. J Am Soc Nephrol 1998;9(suppl):145.